{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:32:36Z","timestamp":1792096356591,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T00:00:00Z","timestamp":1519603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"GlaxoSmithKline Biologicals SA"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,5]]},"DOI":"10.1093\/infdis\/jiy095","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T07:13:32Z","timestamp":1519197212000},"page":"1750-1760","source":"Crossref","is-referenced-by-count":206,"title":["Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older"],"prefix":"10.1093","volume":"217","author":[{"given":"Anthony L","family":"Cunningham","sequence":"first","affiliation":[{"name":"The Westmead Institute for Medical Research, University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C","family":"Heineman","sequence":"additional","affiliation":[{"name":"GSK, King of Prussia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himal","family":"Lal","sequence":"additional","affiliation":[{"name":"GSK, King of Prussia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Godeaux","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Chlibek","sequence":"additional","affiliation":[{"name":"Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinn-Jang","family":"Hwang","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Taipei Veterans General Hospital, and National Yang Ming University School of Medicine, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet E","family":"McElhaney","sequence":"additional","affiliation":[{"name":"Health Sciences North Research Institute, Sudbury, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Vesikari","sequence":"additional","affiliation":[{"name":"Vaccine Research Center, University of Tampere, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Andrews","sequence":"additional","affiliation":[{"name":"Diagnostics Research Group, San Antonio, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Suk","family":"Choi","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Internal Medicine, Korea University College of Medicine, Seoul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Esen","sequence":"additional","affiliation":[{"name":"Institute of Tropical Medicine, University Clinic of Tuebingen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Ikematsu","sequence":"additional","affiliation":[{"name":"Japan Physicians Association, Kanda, Chiyoda-ku, Tokyo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Kovac","family":"Choma","sequence":"additional","affiliation":[{"name":"GSK, Rockville, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlis","family":"Pauksens","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Uppsala University Hospital, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Ravault","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Salaun","sequence":"additional","affiliation":[{"name":"GSK, Rixensart, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tino F","family":"Schwarz","sequence":"additional","affiliation":[{"name":"Central Laboratory and Vaccination Centre, Klinikum W\u00fcrzburg Mitte, Standort Juliusspital, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Smetana","sequence":"additional","affiliation":[{"name":"Faculty of Military Health Sciences, University of Defense, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carline Vanden","family":"Abeele","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Van den Steen","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Vastiau","sequence":"additional","affiliation":[{"name":"GSK, Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily Yin","family":"Weckx","sequence":"additional","affiliation":[{"name":"Federal University of Sao Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron J","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ZOE-50\/70 Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,26]]},"reference":[{"key":"key\n\t\t\t\t20180626074858_CIT0001","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/B978-1-4557-0090-5.00012-4","article-title":"Licensed vaccines. Zoster vaccine","volume-title":"Vaccines","author":"Levin","year":"2013","edition":"6th ed"},{"key":"key\n\t\t\t\t20180626074858_CIT0002","doi-asserted-by":"crossref","first-page":"e004833","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"key\n\t\t\t\t20180626074858_CIT0003","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa1501184","article-title":"Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults","volume":"372","author":"Lal","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626074858_CIT0004","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1603800","article-title":"Efficacy of the herpes zoster subunit vaccine in adults 70 years of age or older","volume":"375","author":"Cunningham","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626074858_CIT0005","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180626074858_CIT0006","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0007","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1086\/528696","article-title":"Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine","volume":"197","author":"Levin","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0008","first-page":"341","article-title":"VZV T cell-mediated immunity","volume":"342","author":"Weinberg","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0009","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1086\/651199","article-title":"Influence of age and nature of primary infection on varicella-zoster virus-specific cell-mediated immune responses","volume":"201","author":"Weinberg","year":"2010","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0010","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.vaccine.2011.04.019","article-title":"Zoster vaccine recommendations: the importance of using a clinically valid correlate of protection","volume":"29","author":"Oxman","year":"2011","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0011","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/cid\/ciw854","article-title":"Effectiveness and duration of protection provided by the live-attenuated herpes zoster vaccine in the medicare population ages 65 years and older","volume":"64","author":"Izurieta","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0012","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/cid\/ciu918","article-title":"Long-term persistence of zoster vaccine efficacy","volume":"60","author":"Morrison","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0013","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/infdis\/jiw047","article-title":"Declining effectiveness of herpes zoster vaccine in adults aged \u226560 years","volume":"213","author":"Tseng","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0014","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/infdis\/157.5.882","article-title":"Western blot analysis of antibody to varicella-zoster virus","volume":"157","author":"Dubey","year":"1988","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0015","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1086\/522123","article-title":"Humoral and cellular immunity to varicella-zoster virus: an overview","volume":"197","author":"Arvin","year":"2008","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0016","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1016\/j.vaccine.2012.01.088","article-title":"Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice","volume":"30","author":"Dendouga","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0017","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/0264-410X(94)00073-V","article-title":"Boosting immune response with a candidate varicella-zoster virus glycoprotein subunit vaccine","volume":"13","author":"Vafai","year":"1995","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0018","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.4049\/jimmunol.1400948","article-title":"Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells","volume":"193","author":"Didierlaurent","year":"2014","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0019","doi-asserted-by":"crossref","first-page":"39475","DOI":"10.1038\/srep39475","article-title":"Central role of CD169+lymph node resident macrophages in the adjuvanticity of the QS-21 component of AS01","volume":"6","author":"Detienne","year":"2016","journal-title":"Sci Rep"},{"key":"key\n\t\t\t\t20180626074858_CIT0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-017-0027-3","article-title":"Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFN\u03b3 response promoting vaccine immunogenicity","volume":"2","author":"Coccia","year":"2017","journal-title":"NPJ Vaccines"},{"key":"key\n\t\t\t\t20180626074858_CIT0021","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/infdis\/jit365","article-title":"Safety and immunogenicity of an AS01-adjuvanted varicella-zoster virus subunit candidate vaccine against herpes zoster in adults >=50 years of age","volume":"208","author":"Chlibek","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0022","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.vaccine.2014.01.019","article-title":"Safety and immunogenicity of three different formulations of an adjuvanted varicella-zoster virus subunit candidate vaccine in older adults: a phase II, randomized, controlled study","volume":"32","author":"Chlibek","year":"2014","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0023","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1093\/infdis\/jis497","article-title":"A phase 1\/2 clinical trial evaluating safety and immunogenicity of a varicella zoster glycoprotein e subunit vaccine candidate in young and older adults","volume":"206","author":"Leroux-Roels","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0024","unstructured":"Pauksens K , VolpeS, SchwarzTFet al. Persistence of immune response to an adjuvanted varicella\u2010zoster virus subunit candidate vaccine for up to year 9 in older adults. IDWeek2017. San Diego. https:\/\/idsa.confex.com\/idsa\/2017\/webprogram\/Paper66091.html. Accessed 24 February 2018."},{"key":"key\n\t\t\t\t20180626074858_CIT0025","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/ofid\/ofv133.1478","article-title":"Persistence of the immune response to an adjuvanted herpes zoster subunit vaccine in healthy older adults: modeling of vaccine-induced immune response, data from a 6-year follow-up study","volume":"2","author":"Lal","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14760584.2017.1329012","article-title":"Vaccine profile of herpes zoster (HZ\/su) subunit vaccine","volume":"16","author":"Cunningham","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180626074858_CIT0027","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1080\/21645515.2016.1154247","article-title":"Comparative preclinical evaluation of AS01 versus other adjuvant systems in a candidate herpes zoster glycoprotein E subunit vaccine","volume":"12","author":"Fochesato","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key\n\t\t\t\t20180626074858_CIT0028","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.vaccine.2015.09.073","article-title":"Long-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults","volume":"34","author":"Chlibek","year":"2016","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0029","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/14760584.2016.1213632","article-title":"Adjuvant system AS01: helping to overcome the challenges of modern vaccines","volume":"16","author":"Didierlaurent","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"key\n\t\t\t\t20180626074858_CIT0030","first-page":"155","article-title":"Varicella zoster virus immune evasion strategies","volume":"342","author":"Abendroth","year":"2010","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0031","doi-asserted-by":"crossref","first-page":"e1006083","DOI":"10.1371\/journal.ppat.1006083","article-title":"Role of occult and post-acute phase replication in protective immunity induced with a novel live attenuated SIV vaccine","volume":"12","author":"Berry","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180626074858_CIT0032","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fimmu.2016.00421","article-title":"Increased TNF-\u03b1\/IFN-\u03b3\/IL-2 and decreased TNF-\u03b1\/IFN-\u03b3 production by central memory T cells are associated with protective responses against bovine tuberculosis following BCG vaccination","volume":"7","author":"Maggioli","year":"2016","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0033","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature21060","article-title":"Sterile protection against human malaria by chemoattenuated PfSPZ vaccine","volume":"542","author":"Mordm\u00fcller","year":"2017","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180626074858_CIT0034","doi-asserted-by":"crossref","first-page":"e01793-16","DOI":"10.1128\/JVI.01793-16","article-title":"Human asymptomatic epitopes identified from the herpes simplex virus tegument protein VP13\/14 (UL47) preferentially recall polyfunctional effector memory CD44high CD62Llow CD8+ TEM cells and protect humanized HLA-A*02:01 transgenic mice against ocular herpesvirus infection","volume":"91","author":"Srivastava","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20180626074858_CIT0035","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nbt.3187","article-title":"COMPASS identifies T-cell subsets correlated with clinical outcomes","volume":"33","author":"Lin","year":"2015","journal-title":"Nat Biotechnol"},{"key":"key\n\t\t\t\t20180626074858_CIT0036","doi-asserted-by":"crossref","first-page":"e91438","DOI":"10.1172\/jci.insight.91438","article-title":"Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients","volume":"2","author":"Gross","year":"2017","journal-title":"JCI Insight"},{"key":"key\n\t\t\t\t20180626074858_CIT0037","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nm1293","article-title":"A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles","volume":"11","author":"Chattopadhyay","year":"2005","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180626074858_CIT0038","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clim.2016.05.007","article-title":"Impact of adjuvants on CD4(+) T cell and B cell responses to a protein antigen vaccine: Results from a phase II, randomized, multicenter trial","volume":"169","author":"Leroux-Roels","year":"2016","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0039","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1017\/CBO9780511545313.040","article-title":"VZV: immunobiology and host response","volume-title":"Human herpesviruses: biology, therapy, and immunoprophylaxis","author":"Arvin","year":"2007"},{"key":"key\n\t\t\t\t20180626074858_CIT0040","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI111678","article-title":"Evolution of recurrent herpes simplex lesions. An immunohistologic study","volume":"75","author":"Cunningham","year":"1985","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180626074858_CIT0041","doi-asserted-by":"crossref","first-page":"e1005892","DOI":"10.1371\/journal.ppat.1005892","article-title":"Defective T memory cell differentiation after varicella zoster vaccination in older individuals","volume":"12","author":"Qi","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180626074858_CIT0042","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.immuni.2008.02.020","article-title":"Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines","volume":"28","author":"Miller","year":"2008","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180626074858_CIT0043","doi-asserted-by":"crossref","first-page":"e0136717","DOI":"10.1371\/journal.pone.0136717","article-title":"Vaccination expands antigen-specific CD4+ memory T cells and mobilizes bystander central memory T cells","volume":"10","author":"Li Causi","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180626074858_CIT0044","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3389\/fimmu.2015.00553","article-title":"Effector and central memory poly-functional CD4(+) and CD8(+) T cells are boosted upon ZOSTAVAX(\u00ae) vaccination","volume":"6","author":"Sei","year":"2015","journal-title":"Front Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0045","doi-asserted-by":"crossref","first-page":"225.1","DOI":"10.4049\/jimmunol.198.Supp.225.1","article-title":"A comparison of the immunogenicity of a live attenuated herpes zoster vaccine (ZV) and the recombinant gE\/AS01B candidate vaccine in older adults","volume":"198","author":"Weinberg","year":"2017","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0046","doi-asserted-by":"crossref","first-page":"7087","DOI":"10.1016\/j.vaccine.2007.07.051","article-title":"Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine","volume":"25","author":"Patterson-Bartlett","year":"2007","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20180626074858_CIT0047","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/infdis\/jiv480","article-title":"Cellular and humoral responses to a second dose of herpes zoster vaccine administered 10 years after the first dose among older adults","volume":"213","author":"Levin","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20180626074858_CIT0048","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.it.2009.04.007","article-title":"T-cell immunosenescence: lessons learned from mouse models of aging","volume":"30","author":"Maue","year":"2009","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20180626074858_CIT0049","doi-asserted-by":"crossref","first-page":"39171","DOI":"10.18632\/oncotarget.10047","article-title":"IL-2 and IL-6 cooperate to enhance the generation of influenza-specific CD8 T cells responding to live influenza virus in aged mice and humans","volume":"7","author":"Zhou","year":"2016","journal-title":"Oncotarget"},{"key":"key\n\t\t\t\t20180626074858_CIT0050","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/infdis\/jit651","article-title":"Correlate of immune protection against HSV-1 genital disease in vaccinated women","volume":"209","author":"Belshe","year":"2014","journal-title":"J Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/217\/11\/1750\/25090178\/jiy095.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T01:57:12Z","timestamp":1693533432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/217\/11\/1750\/4911103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,26]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2018,2,26]]},"published-print":{"date-parts":[[2018,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy095","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6,1]]},"published":{"date-parts":[[2018,2,26]]}}}